Cyclo Therapeutics Inc CYTHW:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/08/21 EST
3.00quote price arrow up+0.15 (+5.26%)
Volume
2,160
52 week range
0.50 - 11.94

...

Loading . . .

KEY STATS

  • Open2.85
  • Day High3.05
  • Day Low2.85
  • Prev Close3.00
  • 52 Week High11.94
  • 52 Week High Date02/09/21
  • 52 Week Low0.50
  • 52 Week Low Date12/09/20
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Cyclo Therapeutics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company. The Company develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease. The Company’s Trappsol Cyclo, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. NPC is a fatal cholesterol metabolism disease that impacts the...
Address
6714 NW 16th Street, Suite B
Gainesville, FL
32653
United States